Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma.

Katharina SeystahlFelix Boakye OppongEmilie Le RhunCaroline HertlerRoger StuppBurt NaborsOlivier ChinotMatthias PreusserThierry GorliaMichael Weller

Published in: Neuro-oncology advances (2022)

LEV is not associated with reduced tolerability of chemoradiotherapy in patients with glioblastoma regarding hematologic toxicity and fatigue. Antiemetic properties of LEV may be beneficial during maintenance temozolomide.

Keyphrases

newly diagnosed
rectal cancer
locally advanced
open label
double blind
placebo controlled
oxidative stress
squamous cell carcinoma
sleep quality
radiation therapy
randomized controlled trial
clinical trial
study protocol